HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Glucose-dependent insulinotropic polypeptide inhibits bone resorption in humans.

AbstractBACKGROUND:
In humans, the pronounced postprandial reduction in bone resorption (decreasing bone resorption markers by around 50%) has been suggested to be caused by gut hormones. Glucose-dependent insulinotropic polypeptide (GIP) is a peptide hormone secreted postprandially from the small intestine. The hormone is known as an incretin hormone, but preclinical studies have suggested that it may also influence bone metabolism, showing both antiresorptive and anabolic effects as reflected by changes in biomechanical measures, microarchitecture, and activity of the bone cells in response to GIP stimulation. Its role in human bone homeostasis, however, is unknown.
OBJECTIVE:
To examine the effect of GIP administration on bone resorption in humans.
MATERIALS AND METHODS:
Plasma samples were obtained from 10 healthy subjects during four conditions: euglycemic (5 mmol/L) and hyperglycemic (12 mmol/L) 90-minute glucose clamps with co-infusion of GIP (4 pmol/kg/min for 15 min, followed by 2 pmol/kg/min for 45 min) or placebo. The samples were analyzed for concentrations of degradation products of C-terminal telopeptide of type I collagen (CTX), a bone resorption marker. RESULTS regarding effects on pancreatic hormone secretion have been published.
RESULTS:
During euglycemia, the decremental area under the curve in CTX was significantly (P < .001) higher during GIP infusion (2084 ± 686 % × min) compared to saline infusion (656 ± 295 % × min). During hyperglycemia, GIP infusion significantly (P < .001) augmented the decremental area under the curve to 2785 ± 446 % × minutes, compared to 1308 ± 448 % × minutes during saline infusion, with CTX values corresponding to 49% of basal values.
CONCLUSIONS:
We conclude that GIP reduces bone resorption in humans, interacting with a possible effect of hyperglycemia.
AuthorsAnne Nissen, Mikkel Christensen, Filip K Knop, Tina Vilsbøll, Jens J Holst, Bolette Hartmann
JournalThe Journal of clinical endocrinology and metabolism (J Clin Endocrinol Metab) Vol. 99 Issue 11 Pg. E2325-9 (Nov 2014) ISSN: 1945-7197 [Electronic] United States
PMID25144635 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers
  • Blood Glucose
  • Collagen Type I
  • Peptides
  • collagen type I trimeric cross-linked peptide
  • Gastric Inhibitory Polypeptide
Topics
  • Adult
  • Biomarkers (blood)
  • Blood Glucose (metabolism)
  • Bone Resorption (drug therapy)
  • Bone and Bones (drug effects)
  • Collagen Type I (blood)
  • Fasting (blood)
  • Gastric Inhibitory Polypeptide (pharmacology, therapeutic use)
  • Glucose Clamp Technique
  • Humans
  • Hyperglycemia (blood)
  • Male
  • Peptides (blood)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: